Rheumatoid arthritis

Novel immunotherapy trial for rheumatoid arthritis

Queensland researchers are hoping a novel immunotherapy for rheumatoid arthritis will ‘frame the discussion’ between dendritic cells and T-cells to dampen down the immune response. A phase 1 clinical trial of DEN-181 has opened in Brisbane at the Princess Alexandra Hospital to test the safety, tolerability and pharmacodynamics of the new agent in adults with ...

Already a member?

Login to keep reading.

© 2021 the limbic